VivoSeq
Other

Rehabilitation

0

Pipeline Programs

16

Active Trials

3

Companies Involved

Rehabilitation is an early-stage landscape with 0 programs across 3 companies. The most active players are Boehringer Ingelheim, Bayer, Ipsen.

Pipeline Metrics

Competitive Density

33/100

Pipeline Velocity

30/100

Mech. Concentration

N/A

Completion Rate

74/100

Attrition Rate

14/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

51

clinical trials

Completed20 · 39%
Unknown status8 · 16%
Recruiting7 · 14%
Active, not recruiting5 · 10%
Terminated5 · 10%
Not yet recruiting4 · 8%
Other2 · 4%

Trial Activity

51 trials

Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients
Recruiting··N/A·NCT07167368·60 enrolled
The Heart Health After Cardiac Treatment Study
Active, not recruiting·UUniversity of California, San Francisco·Preclinical·NCT07158515·100 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)